BACKGROUND: Engraftment failure and delays, likely due to diminished cord blood unit (CBU) potency, remain major barriers to the overall success of unrelated umbilical cord blood transplantation (UCBT). To address this problem, we developed and retrospectively validated a novel scoring system, the Cord Blood Apgar (CBA), which is predictive of engraftment after UCBT. STUDY DESIGN AND METHODS: In a single-center retrospective study, utilizing a database of 435 consecutive single cord myeloablative UCBTs performed between January 1, 2000, to December 31, 2008, precryopreservation and postthaw graft variables (total nucleated cell, CD34+, colony-forming units, mononuclear cell content, and volume) were initially correlated with neutrophil engraftment. Subsequently, based on the magnitude of hazard ratios (HRs) in univariate analysis, a weighted scoring system to predict CBU potency was developed using a randomly selected training data set and internally validated on the remaining data set. RESULTS: The CBA assigns transplanted CBUs three scores: a precryopreservation score (PCS), a postthaw score (PTS), and a composite score (CS), which incorporates the PCS and PTS values. CBA-PCS scores, which could be used for initial unit selection, were predictive of neutrophil (CBA-PCS ≥ 7.75 vs. <7.75, HR 3.5; p < 0.0001) engraftment. Likewise, CBA-PTS and CS scores were strongly predictive of Day 42 neutrophil engraftment (CBA-PTS ≥ 9.5 vs. <9.5, HR 3.16, p < 0.0001; CBA-CS ≥ 17.75 vs. <17.75, HR 4.01, p < 0.0001). CONCLUSION: The CBA is strongly predictive of engraftment after UCBT and shows promise for optimizing screening of CBU donors for transplantation. In the future, a segment could be assayed for the PTS score providing data to apply the CS for final CBU selection.
BACKGROUND: Engraftment failure and delays, likely due to diminished cord blood unit (CBU) potency, remain major barriers to the overall success of unrelated umbilical cord blood transplantation (UCBT). To address this problem, we developed and retrospectively validated a novel scoring system, the Cord Blood Apgar (CBA), which is predictive of engraftment after UCBT. STUDY DESIGN AND METHODS: In a single-center retrospective study, utilizing a database of 435 consecutive single cord myeloablative UCBTs performed between January 1, 2000, to December 31, 2008, precryopreservation and postthaw graft variables (total nucleated cell, CD34+, colony-forming units, mononuclear cell content, and volume) were initially correlated with neutrophil engraftment. Subsequently, based on the magnitude of hazard ratios (HRs) in univariate analysis, a weighted scoring system to predict CBU potency was developed using a randomly selected training data set and internally validated on the remaining data set. RESULTS: The CBA assigns transplanted CBUs three scores: a precryopreservation score (PCS), a postthaw score (PTS), and a composite score (CS), which incorporates the PCS and PTS values. CBA-PCS scores, which could be used for initial unit selection, were predictive of neutrophil (CBA-PCS ≥ 7.75 vs. <7.75, HR 3.5; p < 0.0001) engraftment. Likewise, CBA-PTS and CS scores were strongly predictive of Day 42 neutrophil engraftment (CBA-PTS ≥ 9.5 vs. <9.5, HR 3.16, p < 0.0001; CBA-CS ≥ 17.75 vs. <17.75, HR 4.01, p < 0.0001). CONCLUSION: The CBA is strongly predictive of engraftment after UCBT and shows promise for optimizing screening of CBU donors for transplantation. In the future, a segment could be assayed for the PTS score providing data to apply the CS for final CBU selection.
Authors: J Kurtzberg; M Laughlin; M L Graham; C Smith; J F Olson; E C Halperin; G Ciocci; C Carrier; C E Stevens; P Rubinstein Journal: N Engl J Med Date: 1996-07-18 Impact factor: 91.245
Authors: E Gluckman; V Rocha; A Boyer-Chammard; F Locatelli; W Arcese; R Pasquini; J Ortega; G Souillet; E Ferreira; J P Laporte; M Fernandez; C Chastang Journal: N Engl J Med Date: 1997-08-07 Impact factor: 91.245
Authors: P Rubinstein; L Dobrila; R E Rosenfield; J W Adamson; G Migliaccio; A R Migliaccio; P E Taylor; C E Stevens Journal: Proc Natl Acad Sci U S A Date: 1995-10-24 Impact factor: 11.205
Authors: P Rubinstein; C Carrier; A Scaradavou; J Kurtzberg; J Adamson; A R Migliaccio; R L Berkowitz; M Cabbad; N L Dobrila; P E Taylor; R E Rosenfield; C E Stevens Journal: N Engl J Med Date: 1998-11-26 Impact factor: 91.245
Authors: A P Iori; R Cerretti; L De Felice; M Screnci; A Mengarelli; A Romano; M Caniglia; L Cerilli; G Gentile; M L Moleti; F Giona; F Agostini; I Pasqua; M P Perrone; M R Pinto; L Grapulin; A M Testi; P Martino; G De Rossi; F Mandelli; W Arcese Journal: Bone Marrow Transplant Date: 2004-06 Impact factor: 5.483
Authors: Susan L Staba; Maria L Escolar; Michele Poe; Young Kim; Paul L Martin; Paul Szabolcs; June Allison-Thacker; Susan Wood; David A Wenger; Pablo Rubinstein; John J Hopwood; William Krivit; Joanne Kurtzberg Journal: N Engl J Med Date: 2004-05-06 Impact factor: 91.245
Authors: Troy C Lund; Jessica Liegel; Nelli Bejanyan; Paul J Orchard; Qing Cao; Jakub Tolar; Claudio Brunstein; John E Wagner; Michael R Verneris; Daniel Weisdorf Journal: Am J Hematol Date: 2015-10 Impact factor: 10.047
Authors: Allison Hubel; Ralf Spindler; Julie M Curtsinger; Bruce Lindgren; Sara Wiederoder; David H McKenna Journal: Transfusion Date: 2014-12-19 Impact factor: 3.157
Authors: Karen K Ballen; Brent R Logan; Mary J Laughlin; Wensheng He; Daniel R Ambruso; Susan E Armitage; Rachel L Beddard; Deepika Bhatla; William Y K Hwang; Joseph E Kiss; Gesine Koegler; Joanne Kurtzberg; Arnon Nagler; David Oh; Lawrence D Petz; Thomas H Price; Ralph R Quinones; Voravit Ratanatharathorn; J Douglas Rizzo; Kathleen Sazama; Andromachi Scaradavou; Michael W Schuster; Leonard S Sender; Elizabeth J Shpall; Stephen R Spellman; Millicent Sutton; Lee Ann Weitekamp; John R Wingard; Mary Eapen Journal: Biol Blood Marrow Transplant Date: 2014-12-24 Impact factor: 5.742
Authors: Kristin M Page; Adam Mendizabal; Brigid Betz-Stablein; Stephen Wease; Kevin Shoulars; Tracy Gentry; Vinod K Prasad; Jessica Sun; Shelly Carter; Andrew E Balber; Joanne Kurtzberg Journal: Transfusion Date: 2013-05-27 Impact factor: 3.157
Authors: Eiman Hussein; Todd DeFor; John E Wagner; Darin Sumstad; Claudio G Brunstein; David H McKenna Journal: Transfusion Date: 2019-11-22 Impact factor: 3.157
Authors: Mark van der Garde; Yvette van Hensbergen; Anneke Brand; Manon C Slot; Alice de Graaf-Dijkstra; Arend Mulder; Suzanne M Watt; Jaap Jan Zwaginga Journal: Stem Cells Dev Date: 2015-01-01 Impact factor: 3.272